Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Lat
REST API REST API
Rattus norvegicus
Lat is differentially expressed in 46 experiments: 43 organism parts: kidney, hippocampus, ... (41 more);, 6 disease states: normal, bladder carcinoma, ... (4 more);, 4 compound treatments 4 clinical treatments 2 cohorts and 13 other conditions.
Synonyms MGC108666
Orthologs Lat (Mus musculus)   LAT (Homo sapiens)   (Compare orthologs)
Gene Ontology Term plasma membrane, integrin-mediated signaling pathway, Ras protein signal transduction, SH3/SH2 adaptor activity, immune response, integral to membrane, calcium-mediated signaling, immunological synapse, regulation of T cell activation, gene expression, inflammatory response, mast cell degranulation, intracellular signal transduction
UniProt Accession Q5M8B3, O70601
InterPro Term Linker_for_activat_Tcells_prot
Search EB-eye ENSRNOG00000017429
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15184, E-GEOD-2880, E-GEOD-2852, E-GEOD-3952, E-GEOD-19830, ... (12 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Disease state

studied in E-GEOD-1872, E-GEOD-1843, E-GEOD-594, E-GEOD-464, E-MTAB-104 ... (5 experiments)

Factor Value U/D Experiments
moderate spinal cord injury
1
1
E-GEOD-464
breast carcinoma
1
E-GEOD-1872
cirrhosis
1
E-GEOD-1843
bone fracture
1
E-GEOD-594
bladder carcinoma
1
E-MTAB-104
normal
3
1
22
E-MTAB-104, E-GEOD-594, E-GEOD-1843, E-GEOD-1872


Compound treatment

studied in E-GEOD-2303, E-MEXP-782

Factor Value U/D Experiments
pristane + phytol
1
E-MEXP-782
valproic acid
1
E-GEOD-2303
none
43
1
E-MEXP-782
clofibrate
1
E-GEOD-2303


Clinical treatment

studied in E-GEOD-738, E-MTAB-104

Factor Value U/D Experiments
aortic banding
1
E-GEOD-738
implanted tumor
1
E-MTAB-104
aortic banding - sham
1
E-GEOD-738
no implantation
1
E-MTAB-104


Cohort

studied in E-GEOD-20388

Factor Value U/D Experiments
Cohort 1
1
E-GEOD-20388
Cohort 2
1
E-GEOD-20388


compound_treatment_design

studied in E-TABM-12

Factor Value U/D Experiments
17a-ethynylestradiol
1
E-TABM-12
genestein
1
E-TABM-12


Developmental stage
studied in E-GEOD-4236, E-MEXP-570, E-GEOD-20245

Diet
studied in E-GEOD-21681

Fluidics machine
studied in E-TABM-536

Genetic modification
studied in E-GEOD-6428

Genotype
studied in E-GEOD-20214

Growth condition
studied in E-GEOD-1155, E-GEOD-6102

Individual
studied in E-TABM-536

Material type
studied in E-GEOD-4192, E-MEXP-2527

Protocol type
studied in E-MEXP-1565

Replicate
studied in E-GEOD-4192

Strain or line
studied in E-MTAB-322

Treatment
studied in E-GEOD-16981

Processing time: 0.837 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM